The Florida Breast Cancer Foundation (FBCF), along with those who generously support us with their talent, time, and resources, is working to better the lives of those facing breast cancer in the Florida community. Thanks to the continuing support of Floridians who have purchased the End Breast Cancer specialty license plate, along with the Foundation’s network of breast cancer supporters, survivors, and advocates fighting to end the suffering caused by breast cancer, we have been able to award over $7 million in dedicated funding for education and research programs in the state of Florida.
Only through research will breast cancer be defeated and FBCF continues to challenge the scientific community to design innovative research that will foster new directions for, address neglected issues in, and bring new investigators to the field of breast cancer research. FBCF focuses its funding on research projects that have the potential to make a significant impact on breast cancer, particularly in multidisciplinary and/or multi-institutional collaborations.
2022 Priority Areas:
- Basic, clinical (including novel diagnostic/therapeutic modalities), and translational breast cancer research.
- Understanding the links between environmental factors and breast cancer in Florida.
- Novel epidemiological studies to provide insight on opportunities for improving breast cancer detection and treatment in Florida.
- Psycho-immunologic mechanisms and breast cancer progression: implications for improving outcomes.
- Innovative awards and idea grants
THE APPLICATION PROCESS IS NOW CLOSED
Stay up to date on upcoming funding opportunities by signing up for our newsletter.
SCIENTIFIC GRANT AWARDS CURRENTLY BEING FUNDED
University of Miami: Dr. Rehana Quresh, “Estrone contribute to ER+breast cancer progression in obese postmenopausal female through immune evasion
H. Lee Moffitt Cancer Center & Research Institute. Inc: Dr. Inna Smalley, “Defining and targeting the pro-tumorigenic metabolic microenvironment of leptomeningeal metastasis triple negative breast cancer”
H. Lee Moffitt Cancer Center & Research Institute. Inc: Dr. Smitha Pillai, “Identifying metabolic vulnerabilities induced by acidosis in breast tumor microenvironment”
University of Florida Board of Trustees: Dr. Walter O’Dell and Dr. Karen Daily, “Toward amelioration of cardiac mortality in breast cancer”
H Lee Moffitt Cancer Center & Research Institute. Inc: Dr. Kamran Ahmed, “Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer"
H. Lee Moffitt Cancer Center & Research Institute. Inc: Dr. Marilena Tauro, “A dual epigenetic/autophagy inhibitor as a novel strategy to treat triple negative breast cancer”
University of Florida Board of Trustees: Dr. Perry Johnson.
“ Improving Breast Radiotherapy setup and delivery using mixed reality visualization”
University of Central Florida Research Foundation, Inc: Dr. Deborah Altomare
“Importance of Fibroblast Growth Factor Receptor-4 (FGFR4) in Mediating Breast Cancer Metastasis”
H. Lee Moffitt Cancer Center & Research Institute. Inc: Dr. Ana Gomes, “NADK as an essential metabolic adaptation of metastatic triple negative breast cancer”
To learn more about the current grants being funded, click here.